本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Blueprint Medicines Corporation

129.46
0.0000
成交量:- -
成交額:3.85億
市值:83.80億
市盈率:-52.77
高:129.46
開:129.46
低:129.46
收:129.46
52周最高:129.65
52周最低:73.04
股本:6,473.36萬
流通股本:6,014.42萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.4532
每股收益(LYR):-1.0673
淨資產收益率:-47.71%
總資產收益率:-9.75%
市淨率:24.49
市盈率(LYR):-121.29

資料載入中...

2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/30

重要事件披露

Form 8-K - Current report
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/01

重要事件披露

Form 8-K - Current report
2024/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/21

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]